Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (3), 974-979
- https://doi.org/10.1046/j.1365-2141.2000.02463.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of hemophilia APediatric Radiology, 1997
- Tissue-factor antigen and activity in human coronary atherosclerotic plaquesThe Lancet, 1997
- Acute myocardial infarction, non‐bacterial thrombotic endocarditis, and disseminated intravascular coagulation in a severe hemophiliacAmerican Journal of Hematology, 1990
- Haemophilia protects against ischaemic heart disease: a study of risk factorsBritish Journal of Haematology, 1990
- Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitorAmerican Journal Of Medicine, 1988
- Fatal Myocardial Necrosis Associated with Prothrombin-Complex–Concentrate Therapy in Hemophilia ANew England Journal of Medicine, 1983
- MYOCARDIAL INFARCTION COMPLICATING ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE SUBSTITUTION IN PATIENT WITH HAEMOPHILIA AThe Lancet, 1982
- Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acidThe Journal of Pediatrics, 1981
- Myocardial infarction after factor IX therapyPublished by American Medical Association (AMA) ,1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980